지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
이용수
등록된 정보가 없습니다.
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
Comparing the Mortality Risk between Metabolic Dysfunction-Associated Fatty Liver Disease and Non-Alcoholic Fatty Liver Disease
Diabetes and Metabolism Journal
2023 .03
How to optimize the outcome of liver transplantation for non-alcoholic fatty liver disease
Clinical and Molecular Hepatology
2023 .04
The independent effect of exercise on biopsy proven non-alcoholic fatty liver disease: A systematic review
Clinical and Molecular Hepatology
2023 .04
An analysis of polygenic risk scores for non-alcoholic fatty liver disease
Clinical and Molecular Hepatology
2021 .01
Beyond Liver Disease: Non-Alcoholic Fatty Liver Disease and Advanced Liver Fibrosis in Kidney Disease
Diabetes and Metabolism Journal
2022 .07
Non-invasive imaging biomarkers for liver steatosis in non-alcoholic fatty liver disease: present and future
Clinical and Molecular Hepatology
2023 .02
Long working hours and the risk of non-alcoholic fatty liver disease: a cohort study
대한직업환경의학회 학술대회 논문집
2020 .11
비알코올성 지방간 환자의 간기능 개선
대한한방내과학회지
2020 .01
Novel predictive markers for non-alcoholic fatty liver disease: animal and human studies
한국실험동물학회 학술발표대회 논문집
2016 .08
Non-alcoholic fatty liver disease and the risk of dementia: A meta-analysis of cohort studies
Clinical and Molecular Hepatology
2022 .10
Letter regarding “The usefulness of metabolic score for insulin resistance for the prediction of incident non-alcoholic fatty liver disease in Korean adults”
Clinical and Molecular Hepatology
2023 .01
Correspondence on Letter regarding “Waiting for the changes after the adoption of steatotic liver disease”
Clinical and Molecular Hepatology
2024 .01
Non-alcoholic fatty liver disease and risk of dementia: Unmet need for a pooled analysis of cohort studies
Clinical and Molecular Hepatology
2022 .10
Changing the nomenclature from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease is more than a change in terminology
Clinical and Molecular Hepatology
2023 .04
Should you advocate for hepatocellular carcinoma surveillance in patients with alcohol-related liver disease or non-alcoholic fatty liver disease?
Clinical and Molecular Hepatology
2020 .01
The growing burden of non-alcoholic fatty liver disease on mortality
Clinical and Molecular Hepatology
2023 .04
Non-invasive biomarkers of liver fibrosis in non-alcoholic fatty liver disease
Clinical and Molecular Hepatology
2023 .04
Reply to Letter regarding “COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysis”
Clinical and Molecular Hepatology
2023 .01
Implications of comorbidities in nonalcoholic fatty liver disease
Clinical and Molecular Hepatology
2023 .04
Prognosis and problems after LT for alcoholic liver disease
한국간담췌외과학회 학술대회지
2016 .04
0